These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18410968)

  • 1. Treatment of Clostridium difficile disease in patients not responding to metronidazole.
    Kapoor S
    J Infect; 2008 May; 56(5):394-5. PubMed ID: 18410968
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical inquiries. What are effective therapies for Clostridium difficile-associated diarrhea?
    Ohl ME; Stevermer JJ; Meadows S; Tribuna J; Chek K
    J Fam Pract; 2005 Feb; 54(2):176-8. PubMed ID: 15689297
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduction in Clostridium difficile environmental contamination by hospitalized patients treated with fidaxomicin.
    Biswas JS; Patel A; Otter JA; Wade P; Newsholme W; van Kleef E; Goldenberg SD
    J Hosp Infect; 2015 Jul; 90(3):267-70. PubMed ID: 25728208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium difficile disease and vancomycin--questionable clinical superiority.
    Tarchini G
    Clin Infect Dis; 2011 Jul; 53(2):212. PubMed ID: 21690637
    [No Abstract]   [Full Text] [Related]  

  • 5. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating C. difficile.
    Parmar MS
    CMAJ; 2005 Feb; 172(4):448; author reply 448. PubMed ID: 15710921
    [No Abstract]   [Full Text] [Related]  

  • 7. Vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
    Bishara J; Wattad M; Paul M
    Clin Infect Dis; 2007 Dec; 45(12):1646-7; author reply 1649-51. PubMed ID: 18190329
    [No Abstract]   [Full Text] [Related]  

  • 8. Vancomycin therapy for severe Clostridium difficile-associated diarrhea.
    Huggan PJ; Murdoch DR
    Clin Infect Dis; 2007 Dec; 45(12):1647-8; author reply 1649-51. PubMed ID: 18190330
    [No Abstract]   [Full Text] [Related]  

  • 9. Vancomycin "telephone".
    Drekonja DM
    Clin Infect Dis; 2011 Jul; 53(2):211-2. PubMed ID: 21690636
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic approaches for Clostridium difficile infections.
    Marsh JW; Curry SR
    Curr Protoc Microbiol; 2013 Oct; 30():9A.3.1-9A.3.9. PubMed ID: 24510892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile-associated disease treatment response depends on definition of cure.
    Lawrence SJ; Dubberke ER; Johnson S; Gerding DN
    Clin Infect Dis; 2007 Dec; 45(12):1648; author reply 1649-51. PubMed ID: 18190331
    [No Abstract]   [Full Text] [Related]  

  • 12. Continuation of antibiotics is associated with failure of metronidazole for Clostridium difficile-associated diarrhea.
    Modena S; Gollamudi S; Friedenberg F
    J Clin Gastroenterol; 2006 Jan; 40(1):49-54. PubMed ID: 16340634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
    Tart SB
    J Pharm Pract; 2013 Oct; 26(5):488-90. PubMed ID: 23940121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of clostridium difficile infection.
    Med Lett Drugs Ther; 2011 Feb; 53(1358):14-5. PubMed ID: 21372762
    [No Abstract]   [Full Text] [Related]  

  • 15. C-reactive protein is a useful predictor of metronidazole treatment failure in mild-to-moderate Clostridium difficile infection.
    Farne HA; Martin NK; Main J; Orchard T; Tyrrell-Price J
    Eur J Gastroenterol Hepatol; 2013 Jan; 25(1):33-6. PubMed ID: 23026925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of alternative or adjuvant pharmacologic treatment strategies in the prevention and treatment of Clostridium difficile infection.
    Musgrave CR; Bookstaver PB; Sutton SS; Miller AD
    Int J Infect Dis; 2011 Jul; 15(7):e438-48. PubMed ID: 21596604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea.
    McPherson S; Rees CJ; Ellis R; Soo S; Panter SJ
    Dis Colon Rectum; 2006 May; 49(5):640-5. PubMed ID: 16525744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal Microbiota Transplantation for Primary Clostridium difficile Infection.
    Juul FE; Garborg K; Bretthauer M; Skudal H; Øines MN; Wiig H; Rose Ø; Seip B; Lamont JT; Midtvedt T; Valeur J; Kalager M; Holme Ø; Helsingen L; Løberg M; Adami HO
    N Engl J Med; 2018 Jun; 378(26):2535-2536. PubMed ID: 29860912
    [No Abstract]   [Full Text] [Related]  

  • 19. Clostridium difficile: new therapeutic options.
    Balagopal A; Sears CL
    Curr Opin Pharmacol; 2007 Oct; 7(5):455-8. PubMed ID: 17644040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system.
    Belmares J; Gerding DN; Parada JP; Miskevics S; Weaver F; Johnson S
    J Infect; 2007 Dec; 55(6):495-501. PubMed ID: 17983659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.